Carmen Mignogna

Rome, 00161, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

IFN-α Neutralizing Antibodies Distinguish LADA From Early-onset Type 1 Diabetes.

IFN-α Neutralizing Antibodies Distinguish LADA From Early-onset Type 1 Diabetes.

Journal: The Journal of clinical endocrinology and metabolism

Published: August 27, 2024

Saxagliptin/dapagliflozin is non-inferior to insulin glargine in terms of β-cell function in subjects with latent autoimmune diabetes in adults: A 12-month, randomized, comparator-controlled pilot study.

Saxagliptin/dapagliflozin is non-inferior to insulin glargine in terms of β-cell function in subjects with latent autoimmune diabetes in adults: A 12-month, randomized, comparator-controlled pilot study.

Journal: Diabetes, obesity & metabolism

Published: December 22, 2023

No Differences in Kidney Function Decline Between People With Type 2 Diabetes Starting a Sodium-Glucose Cotransporter 2 Inhibitor or a Glucagon-like Peptide-1 Receptor Agonist: A Real-world Retrospective Comparative Observational Study.

No Differences in Kidney Function Decline Between People With Type 2 Diabetes Starting a Sodium-Glucose Cotransporter 2 Inhibitor or a Glucagon-like Peptide-1 Receptor Agonist: A Real-world Retrospective Comparative Observational Study.

Journal: Clinical therapeutics

Published: November 12, 2023

Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications.

Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications.

Journal: International journal of molecular sciences

Published: September 21, 2023

Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus.

Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus.

Journal: Diabetes & metabolism

Published: August 22, 2023

Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus.

Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus.

Journal: Cardiovascular diabetology

Published: June 26, 2023

MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus.

MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus.

Journal: Diabetes & metabolism

Published: June 23, 2023

Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes.

Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes.

Journal: The Journal of clinical endocrinology and metabolism

Published: November 17, 2022

Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a 6 months follow-up study: The CoVaDiab study I.

Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a 6 months follow-up study: The CoVaDiab study I.

Journal: Diabetes/metabolism research and reviews

Published: August 06, 2022

Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes.

Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes.

Journal: Expert opinion on investigational drugs

Published: December 22, 2021

Diastolic Pressure and ACR Are Modifiable Risk Factors of Arterial Stiffness in T2DM Without Cardiovascular Disease.

Diastolic Pressure and ACR Are Modifiable Risk Factors of Arterial Stiffness in T2DM Without Cardiovascular Disease.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 05, 2021

Development of a clinical risk score to predict death in patients with COVID-19.

Development of a clinical risk score to predict death in patients with COVID-19.

Journal: Diabetes/metabolism research and reviews

Published: August 10, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026